TBRG1 抗体 (N-Term)
(3 references)Quick Overview for TBRG1 抗体 (N-Term) (ABIN6746874)
抗原
See all TBRG1 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- N-Term
-
特异性
- Human TBRG1
-
预测反应
- Percent identity by BLAST analysis: Human, Dog, Bovine, Horse, Pig (100%) Mouse, Rat (92%).
-
纯化方法
- Immunoaffinity purified
-
免疫原
-
Synthetic peptide from N-Terminus of human TBRG1 (Q3YBR2, NP_116200). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey, Galago, Marmoset, Hamster, Panda, Dog, Bovine, Rabbit, Horse, Pig, Opossum, Guinea pig (100%), Mouse, Rat, Elephant (92%), Bat (85%).
Type of Immunogen: Synthetic peptide
-
-
anti-Transforming Growth Factor beta Regulator 1 (TBRG1) (AA 28-130) antibody
TBRG1 适用: 人, 大鼠 WB, ELISA, IF (cc), IF (p), IHC (fro), IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Transforming Growth Factor beta Regulator 1 (TBRG1) (AA 22-150) antibodyTBRG1 适用: 人 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Transforming Growth Factor beta Regulator 1 (TBRG1) (N-Term) antibodyTBRG1 适用: 人, 大鼠, 马, 兔, 小鼠, Cow, 犬, 豚鼠, 斑马鱼 WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody. -
说明
-
Target Species of Antibody: Human
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Distilled water
-
浓度
- Lot specific
-
缓冲液
- Lyophilized from PBS with 2 % sucrose
-
注意事项
- Avoid repeat freeze-thaw cycles.
-
储存条件
- 4 °C,-20 °C
-
储存方法
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
-
: "Adhesion-mediated intracellular redistribution of c-Fas-associated death domain-like IL-1-converting enzyme-like inhibitory protein-long confers resistance to CD95-induced apoptosis in hematopoietic ..." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 168, Issue 5, pp. 2544-53, (2002) (PubMed).
: "Immunohistochemical staining for DNA topoisomerase IIa in Hodgkin's disease." in: American journal of clinical pathology, Vol. 109, Issue 1, pp. 39-44, (1998) (PubMed).
: "Absence of topoisomerase IIbeta in an amsacrine-resistant human leukemia cell line with mutant topoisomerase IIalpha." in: Cancer research, Vol. 58, Issue 23, pp. 5298-300, (1998) (PubMed).
-
: "Adhesion-mediated intracellular redistribution of c-Fas-associated death domain-like IL-1-converting enzyme-like inhibitory protein-long confers resistance to CD95-induced apoptosis in hematopoietic ..." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 168, Issue 5, pp. 2544-53, (2002) (PubMed).
-
-
